Skip to content

Next-generation sequencing (NGS) has fueled a revolution in genomics and precision medicine over the past 15 years. The continuous innovations and improvements in performance, speed and genomic interpretation, coupled with dramatic reductions in cost, have expanded the potential clinical impact of NGS-based solutions. Ranging from panels, exomes or genomes, these genome sequencing core technologies are driving a genomic medicine revolution. 

In this exciting virtual symposium, hosted by Clinical OMICs and sponsored by Illumina, we present the latest advances in applications of NGS in the clinical space. The event features a keynote presentation from Dr. Heidi Rehm, followed by plenary talks focusing on three key areas: 

•    Applications in Genetic Testing

•    Oncology/Cancer Diagnostics

•    Infectious Disease Detection and Testing 

The symposium will also feature an interactive panel discussion, networking opportunities, and a closing roundtable on NGS integration into clinical practice.

Speakers:

Jim Almas, MD
Vice President and National Medical Director of Clinical Effectiveness
Labcorp

 

Katie Siddle, PhD
Postdoctoral Fellow
The Broad Institute

 

Christian Marshall, PhD, FACMG, FCCMG
Molecular Laboratory Director, Division of Genome Diagnostics in Department of Pediatric Laboratory Medicine
The Hospital for Sick Children (SickKids)

 

Heidi Rehm, PhD, FACMG
Chief Genomics Officer, Department of Medicine
Massachusetts General Hospital (MGH)

Date & Time
Apr 28, 2021
10:00 AM - 1:30 PM
Location
Virtual
North America
Topic
Genetic & Rare Diseases
This event has passed